Researchers conducted a small, short-term study to see if an herb called Jadwar (Delphinium denudatum) could help people with a mild thyroid condition called subclinical hypothyroidism. They studied 30 adults who had slightly elevated levels of a hormone called TSH. Half took Jadwar capsules for 56 days, while the other half took a placebo pill that looked the same.
At the end of the study, people taking Jadwar had a greater reduction in their TSH levels compared to the placebo group. They also reported feeling less fatigue and less constipation. There were no reports of side effects during the study, but safety was only checked for a short time.
It is important to be very cautious about these results. The study was small, only lasted 8 weeks, and used a 'single-blind' design, which can introduce bias. It did not measure important long-term health outcomes or long-term safety. Readers should understand this is a very early, preliminary finding. It suggests Jadwar might be worth studying more, but it is far from proving it is a safe or recommended treatment for thyroid issues.